Boswellia carterii Birdwood Topical Microemulsion for the Treatment of Inflammatory Dermatological Conditions; a Prospective Study doi.org/10.26538/tjnpr/v4i8.9
Main Article Content
Abstract
Several dermatological conditions, such as acne, eczema and urticaria, underlie inflammation among its pathogenesis. Boswellia carterii Bird. oleo-gum-resin has been extensively used in Ayurveda, Egyptian and Chinese traditional medicine for its anti-inflammatory activity. The aim of this study is to investigate the therapeutic potential of a topical microemulsion of B. carterii
oleo-gum-resin standardized bioactive fraction on patients with acne, eczema and urticaria. This prospective study included 47 patients; 34 males and 13 females; 8 of which were suffering from acne, 29 from eczema and 10 from urticaria, receiving a topical dose twice daily from the standardized bioactive fraction of B. carterii oleo-gum-resin in the form of topical microemulsion. The number of acne lesions was significantly decreased in all study groups from basal to week 2 and from week 2 to week 4 of the study. Patients' satisfaction was high in all the groups which further ascertained the improvement detected by the doctors' visual inspection. In
conclusion, topical microemulsion of B. carterii oleo-gum-resin standardized bioactive fraction is effective in the treatment of patients with acne, eczema and urticaria.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Kabashima K, Honda T, Ginhoux F, Egawa G. The immunological anatomy of the skin. Nat Rev Immunol. 2019; 19:19–30.
Simpson NB and Cunliffe WJ. Disorders of the Sebaceous Glands. In: Rook’s Textbook of Dermatology. Malden, Massachusetts, USA: Blackwell Publishing, Inc.; 2008: 2121–2196 p.
Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol. 2011; 3:41–49.
Hamm S, Lesellier E, Bleton J, Tchapla A. Optimization of headspace solid phase microextraction for gas chromatography/mass spectrometry analysis of widely different volatility and polarity terpenoids in olibanum. J Chromatogr A. 2003: 1018(1):73–83.
Singh GB and Atal CK. Pharmacology of an extract of Salai guggal ex-Boswellia serrata, a new non-steroidal antiinflammatory agent. Agents Actions. 1986; 18(3–4):407- 412.
Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HPT. Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther. 1992; 261(3):1143–1146.
Ammar NM, Hawary SSE, Mahdy AA, Hussein RA, Okino T. Phytochemical study of the biologically active fractions of the oleo-gum-resins of Boswellia carteri and Commiphora myrrha. Adv Environ Biol. 2013; 7(9):2573–2584.
Siemoneit U, Hofmann B, Kather N, Lamkemeyer T, Madlung J, Franke L, Schneider G, Jauch J, Poeckel D, Werz O.Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. Biochem Pharmacol. 2008; 75(2):503–513.
Zhao X, Liu JP, Zhang X, Li Y. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm. 2006; 327(1–2):58–64.
Djekic L and Primorac M. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides. Int J Pharm. 2008; 352(1–2):231–239.
El Maghraby GM. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: Effect of phase transition. Colloids Surf., B. 2010; 75(2):595–600.
Mostafa D, Ammar N, Abd El-Alim S, Kassem A, Hussein R, Awad G, El-Awdan S. Boswellia carterii Liquisolid Systems with Promoted Anti-inflammatory Activity. Curr Drug Deliv. 2015; 12(4):454–463.
Mostafa DM, Ammar NM, Basha M, Hussein RA, el Awdan S, Awad G. Transdermal microemulsions of Boswellia carterii Bird: formulation, characterization and in vivo evaluation of anti-inflammatory activity. Drug Deliv. 2015; 22(6):748–756.
Singh S, Khajuria A, Taneja SC, Johri RK, Singh J, Qazi GN. Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomed. 2008; 15(6–7):400–407.
Badria FA, Mikhaeil BR, Maatooq GT, Amer MMA. Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii birdwood. Z. Naturforsch., C: J Biosci. 2003; 58(7–8):505–516.
Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatol. 2001; 203:277–279.
Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-κB and activator protein-1 in inflammatory acne lesions in vivo. Am J Clin Pathol. 2005; 166(6):1691–1699.
Jeremy AHT, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Investig Dermatol. 2003; 121(1):20–27.
Sohn A, Frankel A, Patel RV, Goldenberg G. Eczema. MT SINAI J MED: A J Transl Personal Med. 2011; 78(5):730– 739.
Deacock SJ. An approach to the patient with urticaria. Vol. 153, Clin Exp Immunol. 2008; 153:151–161.
Safayhi H, Boden SE, Schweizer S, Ammon HPT. Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Med. 2000; 66(2):110–113.